Nutrition Blood Outcomes Following Tocotrienol N2B "NIIB"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

A natural form of vitamin E called tocotrienol (TCT) has blood thinning and cholesterol lowering properties, both of which may benefit stroke survivors. This study is being conducted to determine the blood thinning and cholesterol lowering properties of TCT in stroke or TIA (transient ischemic attack, which is also referred to as a "mini-stroke") survivors that are receiving the standard treatment for prevention...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 March 2018.

1 Mar 2013 9 May 2013 1 Sep 2018 1 Dec 2018 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


  • Andrew Slivka, MD

  • Cameron Rink, PhD